title: Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
abstract: Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are part of a disease spectrum associated with TDP-43 pathology. Strong evidence supporting this is the existence of kindreds with family members affected by FTD, ALS or mixed features of FTD and ALS, referred to as FTD-MND. Some of these families have linkage to chromosome 9, with hexanucleotide expansion mutation in a noncoding region of C9ORF72. Discovery of the mutation defines c9FTD/ALS. Prior to discovery of mutations in C9ORF72, it was assumed that TDP-43 pathology in c9FTD/ALS was uniform. In this study, we examined the neuropathology and clinical features of 20 cases of c9FTD/ALS from a brain bank for neurodegenerative disorders. Included are six patients clinically diagnosed with ALS, eight FTD, one FTD-MND and four Alzheimer-type dementia. Clinical information was unavailable for one patient. Pathologically, the cases all had TDP-43 pathology, but there were three major pathologic groups: ALS, FTLD-MND and FTLD-TDP. The ALS cases were morphologically similar to typical sporadic ALS with almost no extramotor TDP-43 pathology; all had oligodendroglial cytoplasmic inclusions. The FTLD-MND showed predominantly Mackenzie Type 3 TDP-43 pathology, and all had ALS-like pathology in motor neurons, but more extensive extramotor pathology, with oligodendroglial cytoplasmic inclusions and infrequent hippocampal sclerosis. The FTLD-TDP cases had several features similar to FTLD-TDP due to mutations in the gene for progranulin, including Mackenzie Type 1 TDP-43 pathology with neuronal intranuclear inclusions and hippocampal sclerosis. FTLD-TDP patients were older and some were thought to have Alzheimer-type dementia. In addition to the FTD and ALS clinical presentations, the present study shows that c9FTD/ALS can have other presentations, possibly related to age of onset and the presence of hippocampal sclerosis. Moreover, there is pathologic heterogeneity not only between ALS and FTLD, but also within the FTLD group. Further studies are needed to address the molecular mechanism of clinical and pathological heterogeneity of c9FTD/ALS due to mutations in C9ORF72.
authors.affiliation: Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
authors.forename: Melissa E
authors.initials: ME
authors.lastname: Murray
authors.forename: Mariely
authors.initials: M
authors.lastname: DeJesus-Hernandez
authors.forename: Nicola J
authors.initials: NJ
authors.lastname: Rutherford
authors.forename: Matt
authors.initials: M
authors.lastname: Baker
authors.forename: Ranjan
authors.initials: R
authors.lastname: Duara
authors.forename: Neill R
authors.initials: NR
authors.lastname: Graff-Radford
authors.forename: Zbigniew K
authors.initials: ZK
authors.lastname: Wszolek
authors.forename: Tanis J
authors.initials: TJ
authors.lastname: Ferman
authors.forename: Keith A
authors.initials: KA
authors.lastname: Josephs
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Boylan
authors.forename: Rosa
authors.initials: R
authors.lastname: Rademakers
authors.forename: Dennis W
authors.initials: DW
authors.lastname: Dickson
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics / Q000473:pathology; D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics* / Q000473:pathology*; D000073885:C9orf72 Protein; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D042622:DNA Repeat Expansion / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D005260:Female; D057180:Frontotemporal Dementia / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D045586:Intranuclear Inclusion Bodies / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016472:Motor Neuron Disease / Q000235:genetics / Q000473:pathology; D009046:Motor Neurons / Q000473:pathology; D009154:Mutation / Q000235:genetics; D011506:Proteins / Q000235:genetics*; D012189:Retrospective Studies
chemical_list: D000073885:C9orf72 Protein; C568651:C9orf72 protein, human; D004268:DNA-Binding Proteins; D011506:Proteins
references.citation: Arch Neurol. 2007 Apr;64(4):530-4
references.pmid: 17420314
references.citation: J Neuropathol Exp Neurol. 2008 Apr;67(4):280-98
references.pmid: 18379439
references.citation: Acta Neuropathol. 2008 Jan;115(1):123-31
references.pmid: 18004574
references.citation: Acta Neuropathol. 2006 Nov;112(5):539-49
references.pmid: 17021754
references.citation: Neurology. 2009 May 12;72(19):1669-76
references.pmid: 19433740
references.citation: Ann Neurol. 2007 May;61(5):427-34
references.pmid: 17469116
references.citation: FEBS Lett. 2008 Aug 20;582(19):2899-904
references.pmid: 18656473
references.citation: Arch Neurol. 1985 Nov;42(11):1097-105
references.pmid: 2864910
references.citation: Acta Neuropathol. 2008 Jan;115(1):115-22
references.pmid: 17786458
references.citation: Neuron. 2011 Oct 20;72(2):257-68
references.pmid: 21944779
references.citation: Acta Neuropathol. 2011 Apr;121(4):509-17
references.pmid: 21225272
references.citation: Acta Neuropathol. 2009 Nov;118(5):633-45
references.pmid: 19618195
references.citation: Brain. 2006 Nov;129(Pt 11):3081-90
references.pmid: 17071926
references.citation: J Neuropathol Exp Neurol. 2008 Apr;67(4):271-9
references.pmid: 18379440
references.citation: J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):196-203
references.pmid: 20562461
references.citation: Acta Neuropathol. 1991;82(4):239-59
references.pmid: 1759558
references.citation: J Neuropathol Exp Neurol. 2009 Nov;68(11):1167-76
references.pmid: 19816201
references.citation: Lancet Neurol. 2011 Sep;10(9):785-96
references.pmid: 21802369
references.citation: Acta Neuropathol. 2009 Sep;118(3):349-58
references.pmid: 19455346
references.citation: J Neuropathol Exp Neurol. 2008 Jul;67(7):649-56
references.pmid: 18596548
references.citation: Am J Pathol. 2003 Jan;162(1):213-8
references.pmid: 12507904
references.citation: Neuropathology. 2010 Apr;30(2):103-12
references.pmid: 20102519
references.citation: Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11
references.pmid: 17084815
references.citation: Acta Neuropathol. 2004 Nov;108(5):379-85
references.pmid: 15351890
references.citation: Neurobiol Aging. 2009 May;30(5):739-51
references.pmid: 17949857
references.citation: Semin Neurol. 2007 Feb;27(1):48-57
references.pmid: 17226741
references.citation: Lancet Neurol. 2010 Oct;9(10):986-94
references.pmid: 20801717
references.citation: BMC Neurol. 2006 Dec 13;6:44
references.pmid: 17166276
references.citation: Am J Pathol. 2006 Oct;169(4):1343-52
references.pmid: 17003490
references.citation: Eur J Neurol. 2010 Jul;17(7):969-75
references.pmid: 20236174
references.citation: Neurology. 2006 Mar 28;66(6):839-44
references.pmid: 16421333
references.citation: Lancet Neurol. 2010 Oct;9(10):978-85
references.pmid: 20801718
references.citation: Arch Neurol. 2008 May;65(5):636-41
references.pmid: 18474740
references.citation: Nat Genet. 2008 May;40(5):572-4
references.pmid: 18372902
references.citation: Acta Neuropathol. 2007 Jul;114(1):49-54
references.pmid: 17458552
references.citation: Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
references.pmid: 11464847
references.citation: Lancet Neurol. 2007 Oct;6(10):857-68
references.pmid: 17826340
references.citation: Science. 2008 Mar 21;319(5870):1668-72
references.pmid: 18309045
references.citation: Mov Disord. 2009 Sep 15;24(12):1843-7
references.pmid: 19609911
references.citation: Neuron. 2011 Oct 20;72(2):245-56
references.pmid: 21944778
references.citation: Acta Neuropathol. 2007 May;113(5):535-42
references.pmid: 17333220
references.citation: Acta Neuropathol. 2003 Jan;105(1):14-7
references.pmid: 12471455
references.citation: Nat Genet. 2010 Mar;42(3):234-9
references.pmid: 20154673
references.citation: Arch Neurol. 2010 May;67(5):606-16
references.pmid: 20457961
references.citation: J Neuropathol Exp Neurol. 2007 Mar;66(3):177-83
references.pmid: 17356379
references.citation: Ann Neurol. 2007 May;61(5):435-45
references.pmid: 17469117
references.citation: Neurology. 2002 Oct 8;59(7):1077-9
references.pmid: 12370467
references.citation: Acta Neuropathol. 2007 Jul;114(1):71-9
references.pmid: 17569066
references.citation: Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):364-8
references.pmid: 21346515
references.citation: Acta Neuropathol. 2007 Jul;114(1):5-22
references.pmid: 17579875
references.citation: Neurobiol Aging. 1992 Jan-Feb;13(1):179-89
references.pmid: 1311804
references.citation: Neurobiol Aging. 2007 Nov;28(11):1718-22
references.pmid: 16930776
references.citation: Brain. 2006 Apr;129(Pt 4):868-76
references.pmid: 16495328
references.citation: J Neuropathol Exp Neurol. 2007 Feb;66(2):142-51
references.pmid: 17278999
references.citation: Lab Invest. 1990 Jul;63(1):87-99
references.pmid: 2165197
references.citation: Nature. 2006 Aug 24;442(7105):916-9
references.pmid: 16862116
references.citation: Arch Neurol. 2007 Feb;64(2):240-5
references.pmid: 17296840
references.citation: Mov Disord. 2008 Jun 15;23(8):1168-73
references.pmid: 18442119
references.citation: Acta Neuropathol. 2010 Jan;119(1):1-4
references.pmid: 19924424
references.citation: Acta Neuropathol. 2011 Jul;122(1):111-3
references.pmid: 21644037
references.citation: J Mol Neurosci. 2011 Nov;45(3):359-65
references.pmid: 21656039
references.citation: Dement Geriatr Cogn Disord. 2004;17(4):333-6
references.pmid: 15178948
references.citation: PLoS Genet. 2008 Sep 19;4(9):e1000193
references.pmid: 18802454
references.citation: J Neurol. 2011 Apr;258(4):647-55
references.pmid: 21072532
references.citation: BMC Neurol. 2008 Aug 29;8:32
references.pmid: 18755042
references.citation: Science. 2006 Oct 6;314(5796):130-3
references.pmid: 17023659
references.citation: J Neurol Sci. 2010 Nov 15;298(1-2):70-7
references.pmid: 20810131
references.citation: Neurology. 2003 Mar 25;60(6):1005-11
references.pmid: 12654969
references.citation: Nat Genet. 2009 Oct;41(10):1083-7
references.pmid: 19734901